Stay updated on ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial

Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed a citation regarding the safety, efficacy, and tolerability of efgartigimod in patients with generalized myasthenia gravis, which was previously included.
    Difference
    0.3%
    Check dated 2025-05-08T14:34:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:40:26.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the details of a Phase 3 trial for ARGX-113 in patients with generalized Myasthenia Gravis, including inclusion and exclusion criteria, and the study director's name. A new version number has been added.
    Difference
    11%
    Check dated 2025-04-16T22:26:45.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T17:01:43.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T01:24:20.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T23:22:01.000Z thumbnail image

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.